Theranyx Sarl:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Theranyx Sarl - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11272
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Theranyx Sarl is a bio technology company that develops novel therapeutic drugs and solutions to treat cancer. The company’s main line business involved in generation of functional antibodies to target GPCRs and ion channel receptors. Its antibodies named as Therabodies has scope in target validation, diagnostics, therapeutic use and antibody drug conjugate (ADC). The company collaborated with biotechnology and pharmaceutical companies for developing novel targets to identify cancer indications. It developed a robust platform to develop purified, stabilized and functional membrane proteins that are used for the development of novel therapeutic molecules. Theranyx is headquartered in Marseille, Cedex , France.

Theranyx Sarl – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Theranyx Sarl, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Theranyx Sarl, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Theranyx Sarl, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Theranyx Sarl, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Theranyx Sarl, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Theranyx Sarl, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Tetragenetics Enters into Agreement with Theranyx 10
LegoChem Biosciences Enters into Agreement with Theranyx 11
Debt Offering 12
Theranyx Raises USD0.4 Million in Private Placement of Bonds 12
Theranyx Sarl – Key Competitors 13
Theranyx Sarl – Key Employees 14
Theranyx Sarl – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Theranyx Sarl, Pharmaceuticals & Healthcare, Key Facts 2
Theranyx Sarl, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Theranyx Sarl, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Theranyx Sarl, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Theranyx Sarl, Deals By Therapy Area, 2012 to YTD 2018 8
Theranyx Sarl, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Tetragenetics Enters into Agreement with Theranyx 10
LegoChem Biosciences Enters into Agreement with Theranyx 11
Theranyx Raises USD0.4 Million in Private Placement of Bonds 12
Theranyx Sarl, Key Competitors 13
Theranyx Sarl, Key Employees 14

List of Figures
Theranyx Sarl, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Theranyx Sarl, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Theranyx Sarl, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Theranyx Sarl, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Theranyx Sarl, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Theranyx Sarl, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Theranyx Sarl, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Theranyx Sarl, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Theranyx Sarl:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Blueprint Medicines Corp (BPMC):企業の財務・戦略的SWOT分析
    Summary Blueprint Medicines Corp (Blueprint Medicines), formerly Hoyle Pharmaceuticals Inc, discovers and develops precision therapies for the treatment of cancers and rare diseases. The company offers AYVAKIT (avapritinib) medicine to treat gastrointestinal stromal tumor (GIST); and GAVRETO (pralse …
  • Lexmark International Inc:企業の戦略的SWOT分析
    Lexmark International Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Amedisys Inc (AMED)-製薬・医療分野:企業M&A・提携分析
    Summary Amedisys Inc (Amedisys) is a healthcare company that offers home health care, hospice service and personal care. The company provides practical nursing services and occupational therapy, comfort and support services for those are facing a terminal illness. It also provides speech pathology, …
  • Toyo Tire & Rubber Co Ltd (5105):企業の財務・戦略的SWOT分析
    Toyo Tire & Rubber Co Ltd (5105) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Campine NV (CAMB):企業の財務・戦略的SWOT分析
    Campine NV (CAMB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Activision Blizzard Inc (ATVI):企業の財務・戦略的SWOT分析
    Activision Blizzard Inc (ATVI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Doosan Fuel Cell America Inc:電力:M&Aディール及び事業提携情報
    Summary Doosan Fuel Cell America Inc (Doosan Fuel Cell), formerly Quantum Leap Technology Inc, a subsidiary of Doosan Corp, is a energy solution provider that manufactures and markets clean energy solutions. The company provides installation, remote monitoring and control, equipment service, financi …
  • The Japan Steel Works Ltd:企業の戦略・SWOT・財務情報
    The Japan Steel Works Ltd - Strategy, SWOT and Corporate Finance Report Summary The Japan Steel Works Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • WestWind Energy Pty Ltd:電力:M&Aディール及び事業提携情報
    Summary WestWind Energy Pty Ltd (West Wind) is a renewable energy company that offers development, construction, operation and management of wind farms and other energy projects. The company provides energy consultation, planning, and maintenance services. It also operates and maintains wind turbine …
  • ConMed Corp (CNMD):企業の財務・戦略的SWOT分析
    ConMed Corp (CNMD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • CardioDx Inc:医療機器:M&Aディール及び事業提携情報
    Summary CardioDx Inc (CardioDx) is a cardiovascular genomic diagnostics company. It undertakes the development of clinically validated tests in the areas of coronary artery disease, cardiac arrhythmias and heart failure. The company’s flagship product, Corus CAD gene expression test is used for asse …
  • Ossur hf (OSSR):企業の財務・戦略的SWOT分析
    Ossur hf (OSSR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Seaboard Corp (SEB):企業の財務・戦略的SWOT分析
    Seaboard Corp (SEB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Exiqon AS-医療機器分野:企業M&A・提携分析
    Summary Exiqon A/S (Exiqon), a subsidiary of Qiagen NV is a medical device company that develops, manufactures and markets molecular diagnostic test products. The company’s product categories include microRNA research, incRNA research, mRNA research, DNA research, custom oligos and other reagent pro …
  • Carlsberg AS (CARL B):企業の財務・戦略的SWOT分析
    Carlsberg AS (CARL B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Blue Cross and Blue Shield of Florida Inc:企業の戦略的SWOT分析
    Blue Cross and Blue Shield of Florida Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Warren Resources Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Warren Resources Inc (Warren Resources) is an oil and gas company that acquires, explores and develops crude oil and natural gas in the US. The company priovides exploration and development of waterflood oil recovery properties in the Wilmington Field in the Los Angeles Basin of California. …
  • Nestle USA, Inc.:企業の戦略・SWOT・財務情報
    Nestle USA, Inc. - Strategy, SWOT and Corporate Finance Report Summary Nestle USA, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Digital China Holdings Limited:企業の戦略・SWOT・財務分析
    Digital China Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Digital China Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Carr’s Group Plc (CARR):企業の財務・戦略的SWOT分析
    Carr's Group Plc (CARR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆